GRIN2C | Glutamate receptor, ionotropic, N-methyl D-aspartate 2C | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GRIN2D | Glutamate receptor, ionotropic, N-methyl D-aspartate 2D | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GRIN3A | Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GRIN3B | Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GRM5 | Glutamate receptor, metabotropic 5 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GSS | Glutathione synthetase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GUCY1A2 | Guanylate cyclase 1, soluble, alpha 2 | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
HBA1 | Hemoglobin, alpha 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HBA2 | Hemoglobin, alpha 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HBB | Hemoglobin, beta | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HCAR2 | Hydroxycarboxylic acid receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
HCAR3 | Hydroxycarboxylic acid receptor 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HDAC1 | Histone deacetylase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HDAC9 | Histone deacetylase 9 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
HPRT1 | Hypoxanthine phosphoribosyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
HRH2 | Histamine receptor H2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HRH3 | Histamine receptor H3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HTR1F | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
IFNAR1 | Interferon (alpha, beta and omega) receptor 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IFNAR2 | Interferon (alpha, beta and omega) receptor 2 | Cancer-related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
IFNG | Interferon, gamma | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IFNGR1 | Interferon gamma receptor 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IFNGR2 | Interferon gamma receptor 2 (interferon gamma transducer 1) | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
IGF1R | Insulin-like growth factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
IL11RA | Interleukin 11 receptor, alpha | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL17A | Interleukin 17A | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |